D. İnce Et Al. , "Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?," PEDIATRIC BLOOD & CANCER , vol.65, 2018
İnce, D. Et Al. 2018. Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?. PEDIATRIC BLOOD & CANCER , vol.65 .
İnce, D., Erdem, M., Kizmazoglu, D., Cecen, E., Ozer, E., & Olgun, N., (2018). Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?. PEDIATRIC BLOOD & CANCER , vol.65.
İnce, DİLEK Et Al. "Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?," PEDIATRIC BLOOD & CANCER , vol.65, 2018
İnce, DİLEK Et Al. "Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?." PEDIATRIC BLOOD & CANCER , vol.65, 2018
İnce, D. Et Al. (2018) . "Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?." PEDIATRIC BLOOD & CANCER , vol.65.
@article{article, author={DİLEK İNCE Et Al. }, title={Could the Residuel Tumor Histopathology be a Therapeutic Directing Effect in Intermediate Risk Neuroblastoma?}, journal={PEDIATRIC BLOOD & CANCER}, year=2018}